| J3262 | Injection, tocilizumab, 1 mg | 61,200 | $10 | $306K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,230 | $30 | $245.7K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,690 | $30 | $147.9K |
| J0897 | Injection, denosumab, 1 mg | 3,960 | $20 | $71.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 4,950 | $10 | $49.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 520 | $90 | $43.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 400 | $90 | $38K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 160 | $50 | $8.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 70 | $110 | $7.5K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 290 | $20 | $6.1K |